| Cash flow (USD) | Q2 2026 ended Jun 28, 2026 | Q1 2026 ended Mar 29, 2026 | Q4 2025 ended Dec 28, 2025 | Q3 2025 ended Sep 28, 2025 | Q2 2025 ended Jun 29, 2025 | Q1 2025 ended Mar 30, 2025 | Q4 2024 ended Dec 29, 2024 | Q3 2024 ended Sep 29, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | 5.53B | 5.24B | 5.12B | 5.15B | 5.54B | 11.00B | 3.43B | 2.69B |
| Depreciation and amortization | 1.96B | 2.00B | 2.01B | 1.78B | 1.94B | 1.77B | 1.90B | 1.85B |
| Stock-based compensation | 458.00M | 300.00M | 309.00M | 347.00M | 410.00M | 288.00M | 238.00M | 295.00M |
| Cash from operations | 8.62B | 2.51B | 7.31B | 9.17B | 3.88B | 4.17B | 6.98B | 7.99B |
| Capital expenditure | -1.32B | -1.05B | -1.84B | -1.16B | -1.04B | -795.00M | -1.61B | -1.03B |
| Free cash flow | 7.29B | 1.47B | 5.47B | 8.01B | 2.83B | 3.38B | 5.37B | 6.96B |
| Acquisitions | 17.24B | -17.50B | -3.04B | -1.00M | -14.46B | 0 | -1.00M | -338.00M |
| Cash from investing | -1.11B | -1.04B | -4.49B | -542.00M | -18.26B | -297.00M | -1.32B | -3.13B |
| Share buybacks | -221.00M | -4.03B | -1.92B | -1.90B | 0 | -2.13B | -282.00M | -539.00M |
| Net debt issued | 0 | 0 | 0 | 0 | 0 | 9.14B | 0 | 1.00M |
| Cash from financing | -8.78B | 530.00M | -1.37B | -8.93B | -5.67B | 10.42B | -1.34B | -9.88B |
| Net change in cash | -1.27B | 1.98B | 1.48B | -346.00M | -19.90B | 14.37B | 4.13B | -4.90B |
From Johnson & Johnson's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.